Medical packaging specialist Gerresheimer AG will consider cutting 20-30 managerial roles worldwide as part of reorganization plans. One board member, Stefan Grote, has already left the company.
Spokesman Jens Kürten said the company is aiming for "leaner management", with some functions merged. Grote will not be replaced, he told European Plastics News.
The Wackerdorf, Germany-based company also is reorganizing the business into three divisions; Life Science Research, Primary Packaging Glass and Plastics and Devices.
"Lifescience Research will stay the same but there will be two new divisions," said Kürten. "Primary Packaging Glass, which will provide standard glass pharmaceutical items such as ampoules and bottles, and Plastics and Devices, which will provide more customized solutions."
Kürten said the company decided to change its structure to align itself better with the market and that no factory floor jobs will be cut. There are also no plans to close plants.
"For last six years, the business was split according to materials and technology, how we produce things," he said. "We can now offer customers different solutions from the same division."
Gerresheimer will assess its portfolio to examine if it will write off a few individual assets, leading to a non-cash impairment of 5 million euros.
Moving forward, primary packaging glass growth will come from emerging markets, while systems and devices growth will be in Europe and the United States, Kürten said.